As of November 2024, Bliss GVS Pharma has a market cap of $159.94M. This makes Bliss GVS Pharma the world's 18664th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $147.46M | -5.42% |
2023 | $155.90M | 72.17% |
2022 | $90.55M | -30.18% |
2021 | $129.70M | -48.70% |
2020 | $252.83M | 34.14% |
2019 | $188.48M | -8.67% |
2018 | $206.37M | -22.17% |
2017 | $265.15M | 36.12% |
2016 | $194.80M | -11.53% |
2015 | $220.19M | 177.46% |
2014 | $79.36M | 52.89% |
2013 | $51.90M | -2.47% |
2012 | $53.22M | 100.71% |
2011 | $26.52M | -38.55% |
2010 | $43.15M | - |